Výsledky vyhledávání - "Katarina Ludajic"

P-015: Is it time to revisit role of PET-CT imaging and its integration with other parameters in International Myeloma Working Group (IMWG) response assessment criteria?

Autor: Jayant Narang, Zsolt Somodi, Kimberely Fernandes-Thomas, Shweta Narang, Katarina Ludajic, Joseph R. Mikhael, Surabhi Bajpai, Arvin Kheterpal

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S47

Background The landscape of imaging in multiple myeloma has changed drastically since the publication of IMWG 2016 criteria. 18 F-FDG PET-CT (PET-CT) is being used more frequently, for staging, prognosis and clinical decision making. PET-CT is useful

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cad013a3982553d95aba646eb2aad844
https://doi.org/10.1016/s2152-2650(21)02149-2

Zobrazit plný text záznamu

Comparison of CT and PET-Based Assessments per Lugano Criteria in FDG-Avid Lymphoma- a Retrospective Analysis of Independent Review Assessments

Autor: Rudresh Jarecha, Sayali Karve, Michael D O'Connor, Shweta Narang, Manish Sharma, Katarina Ludajic, Jayant Narang, Surabhi Bajpai

Publikováno v: Blood. 134:5277-5277

Background: The Lugano classification criteria introduced in 2014 is widely used in clinical trials as well as in clinical practice for response assessment in Lymphoma. The criteria recommend a combination of disease morphology assessment using Compu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::998bfb6ca4101d0c1006866b225b4d19
https://doi.org/10.1182/blood-2019-130570

Zobrazit plný text záznamu

Retrospective comparison of Cheson 2007 and Lugano classification criteria in independent review assessment of FDG-avid lymphomas

Autor: Katarina Ludajic, Rudresh Jarecha, Surabhi Bajpai, Manish Sharma, Sayali Karve, Oliver Bohnsack, Jayant Narang

Publikováno v: Journal of Clinical Oncology. 37:e19015-e19015

e19015 Background: Revised Response Criteria in Malignant Lymphoma (Cheson 2007) and Lugano Classification are the most commonly used guidelines to assess response to treatment in lymphoma in clinical trials. While not drastically different from Ches

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5c76418599d25e109f8431d541e67268
https://doi.org/10.1200/jco.2019.37.15_suppl.e19015

Zobrazit plný text záznamu

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation

Autor: Agathe Rosenmayr, Heike Bickeböller, Yesilda Balavarca, David Pohlreich, Gottfried Fischer, Katarina Ludajic, Hildegard T. Greinix, Peter Kalhs, Ingrid Fae, Michal Kouba

Publikováno v: Bone Marrow Transplantation. 44:97-103

Interactions of polymorphic killer Ig-like receptor (KIR) receptors with KIR ligands have been shown to modify the outcome of hematopoietic SCT (HSCT). The association of these genetic factors with different transplantation endpoints, however, varies

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6baff95677a728ede8c0f7cad1334737
https://doi.org/10.1038/bmt.2008.432

Zobrazit plný text záznamu

Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients

Autor: Hildegard T. Greinix, Heike Bickeböller, Michal Kouba, Ingrid Fae, Yesilda Balavarca, Katarina Ludajic, Gottfried Fischer, Peter Kalhs, Marie Dobrovolna, Agathe Rosenmayr, David Pohlreich

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(11)

We investigated the impact of ABO and Rhesus (Rh) blood group matching on the outcome of hematopoietic stem cell transplantation (HSCT) of 154 patients matched at 10/10 HLA loci with unrelated donors. ABO and Rh, as potential risk factors, were model

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c093060a8ab0a8d250b4fdca48a084e
https://pubmed.ncbi.nlm.nih.gov/19822299

Zobrazit plný text záznamu

Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT

Autor: Yesilda Balavarca, Michal Kouba, Milena Vrana, Katarina Ludajic, Heike Bickeböller, Agathe Rosenmayr, David Pohlreich, Gottfried Fischer, Hildegard T. Greinix, Marie Dobrovolna, Peter Kalhs, Ingrid Fae

Publikováno v: British journal of haematology. 142(3)

The interpretation of the role of HLA-DPB1 in unrelated haematopoietic stem cell transplantation (HSCT) is subject to discussion. We have investigated the role of HLA-DPB1 allele matching in HSCT outcomes in 161 recipients who were HLA-A, -B, -C, -DR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5ecd20786adbfdf48fa0d8ba36a023
https://pubmed.ncbi.nlm.nih.gov/18544086

Zobrazit plný text záznamu

Adaptation and modification of the immune related response criteria (IRRC): IrRECIST

Autor: Oliver Bohnsack, Katarina Ludajic, Axel Hoos

Publikováno v: Journal of Clinical Oncology. 32:e22121-e22121

e22121 Background: The immune related response criteria were published in November 2009. RECIST published in 2000 had its shortcomings for targeted immunotherapy in oncology and still has with its ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::366c12c511e835e090e02956d547dda3
https://doi.org/10.1200/jco.2014.32.15_suppl.e22121

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání